Multimorbidity, P4 medicine and holism

Journal of Evaluation in Clinical Practice

Volumn 23, Issue 1, 2017, Pages 213-215

  Marcum, James A ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

causality; humanity; multimorbidity; philosophy of medicine

Indexed keywords

CAUSALITY; CLINICAL EFFECTIVENESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HOLISTIC CARE; HUMAN; MORBIDITY; MULTIMORBIDITY; NOTE; P4 MEDICINE; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PERSONALIZED MEDICINE; PHENOMENOLOGY; PREDICTION; PREVENTIVE MEDICINE; ENVIRONMENT; HEALTH BEHAVIOR; MULTIPLE CHRONIC CONDITIONS; PHILOSOPHY; SOCIAL ENVIRONMENT; SOCIOECONOMICS;

ENVIRONMENT; HEALTH BEHAVIOR; HOLISTIC HEALTH; HUMANS; MULTIPLE CHRONIC CONDITIONS; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS;

EID: 84978485758     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12588     Document Type: Note

References (12)

1. Sturmberg, J. P., Bennett, J. M., Martin, C. M. & Picard, M. (2016) “Multimorbidity” as the manifestation of network disturbances: implications for whole person care. Journal of Evaluation in Clinical Practice, 23, 199–208.
2. Marcum, J. A. (2009) The Conceptual Foundations of Systems Biology: An Introduction. New York: Nova Science Publishers.
3. Gatherer, D. (2010) So what do we really mean when we say that systems biology is holistic? BMC Systems Biology, 4 (1), 22. DOI: 10.1186/1752-0509-4-22.
4. Vogt, H., Hofmann, B. & Getz, L. (2016) The new holism: P4 systems medicine and the medicalization of health and life itself. Medicine, Health Care and Philosophy. DOI: 10.1007/s11019-016-9683-8.
5. Picard, M., Juster, R. P. & Sabiston, C. M. (2013) Is the whole greater than the sum of the parts? Self-rated health and transdisciplinarity. Health, 5 (12a). DOI: 10.4236/health.2013.512A004.
6. Cassell, E. J. (2012) The Nature of Healing: The Modern Practice of Medicine. New York: Oxford University Press.
7. Hood, L. & Friend, S. H. (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Reviews. Clinical Oncology, 8 (3), 184–187.
8. Hood, L. & Flores, M. (2012) A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnology, 29 (6), 613–624.
9. Jameson, J. L. & Longo, D. L. (2015) Precision medicine—personalized, problematic, and promising. New England Journal of Medicine, 372 (23), 2229–2234.
10. Pravettoni, G. & Gorini, A. (2011) A P5 cancer medicine approach: why personalized medicine cannot ignore psychology. Journal of Evaluation in Clinical Practice, 17 (4), 594–596.
11. Özdemir, V., Fisher, E., Dove, E. S., Burton, H., Wright, G. E., Masellis, M. & Warnich, L. (2012) End of the beginning and public health pharmacogenomics: knowledge in “mode 2” and P5 medicine. Current Pharmacogenomics and Personalized Medicine, 10 (1), 1–6.
12. Bragazzi, N. L. (2013) From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and “augmented” medicine: some considerations on Salvatore Iaconesi's clinical story. Patient Preference and Adherence, 7, 353–358.